☰
The trial’s interim results met the expectations of the primary endpoints that include safety, tolerability and PK Clinical-stage biotech company, DiaMedica Therapeutics Inc, recently announced the interim results of Phase 1b study o....
Blue Prism, a UK based multinational software company, recently declared to acquire UK-headquartered fast-growing technology company, Thoughtonomy. The buyout is likely to close by July 2019, claim sources. The integration of this AI techn....
The partnership was announced at Plug & Play’s headquarter in Sunnyvale, California Nexen Tire, a leading tire manufacturer, recently announced that it has entered into a partnership with US-based Plug & Play, an early stage ....
Celyad, a biopharmaceutical company focused on the advancement of CAR-T cell therapies, has confirmed updated clinical data for the CYAD-01 program in r/r AML and MDS, presented through a poster presentation session on June 15, 2019 in Amst....
The New York-based Thrive Global, has reportedly signed a partnership with P&G, the American multinational consumer goods corporation to combine behavioral science and daily habits pertaining to P&G’s products to help consumer....
The Phase 1b/2 clinical trial assessed the efficacies of vecabrutinib in patients suffering from CLL & other B-Cell related malignancies. The preliminary data reported at the EHA meeting was from over 23 patients that were treated in....
The company expects to generate more than $300 million in sales by 2020 Endonovo Therapeutics, a commercial-stage developer of non-invasive medical devices that are designed to deliver its proprietary Electroceutical therapy, recently anno....
Concert Pharmaceuticals, Inc., a clinical biopharmaceutical company, reportedly announced positive outcomes from two studies in its Phase 1 program assessing the effects of CTP-692, a novel deuterium-modified form of D-serine being created ....
Amid clash with the U.S. government, the Chinese company says US-based Verizon is liable to pay fees for more than 230 of its patents. Huawei, the Chinese telecommunications equipment company recently demanded $1 billion patent licensing f....
Data to be presented at the European Congress of Rheumatology will confirm the efficacy and safety of the anti-TNF biosimilars and high adherence of patients who are being treated Biogen, a multinational biotechnology company, recently ann....
